AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · Senate · $60,000.00 income · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Issues related to 340b

Medicare/Medicaid

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicaid rebates

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.